Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
International Journal of Cardiology|January 31, 2025
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndromeVincenzo De Sio, Felice Gragnano, Antonio Capolongo, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Thrombosis Research|April 14, 2017
Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosisPaolo Prandoni, Valentina Vedovetto, Maurizio Ciammaichella, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.
Lupus Science & Medicine|June 14, 2022
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, et al.
Journal of Clinical Medicine|April 13, 2024
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF RegistryDaniela Poli, Emilia Antonucci, Walter Ageno, et al.
Blood Advances|August 1, 2022
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis studyGualtiero Palareti, Daniela Poli, Walter Ageno, et al.
The American Journal of Cardiology|October 6, 2019
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)Paolo Calabrò, Elisabetta Moscarella, Felice Gragnano, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) StudyElena Gkrouzman, Rohan Willis, Danieli Andrade, et al.
Pageof 25